Genomic assessment distinguishes intrapulmonary metastases from synchronous primary lung cancers.

导出 OA

翻译打印收藏纠错

第一作者： Erin M,Corsini

第一单位： Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

作者： Erin M,Corsini ^[1] ; Jinliang,Wang ^[2] ; Chia-Chin,Wu ^[3] ; Junya,Fujimoto ^[4] ; Marcelo V,Negrao ^[5] ; Runzhe,Chen ^[2] ; Kelly,Quek ^[2] ; Kyle G,Mitchell ^[4] ; Chi-Wan B,Chow ^[2] ; Latasha,Little ^[1] ; Curtis,Gumbs ^[5] ; Xingzhi,Song ^[4] ; Carmen,Behrens ^[4] ; Arlene M,Correa ^[4] ; Mara B,Antonoff ^[5] ; Stephen G,Swisher ^[1] ; John V,Heymach ^[1] ; Jianhua,Zhang ^[1] ; Ignacio I,Wistuba ^[2] ; P Andrew,Futreal ^[4] ; Boris,Sepesi ^[5] ; Jianjun,Zhang ^[4]

作者单位： Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. ^[1] Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. ^[2] Department of Medical Oncology, Chinese PLA General Hospital, Beijing 100853, China. ^[3] Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. ^[4] Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. ^[5]

关键词 Non-small cell lung cancer gene sequencing genomic heterogeneity multiple synchronous lung cancers

DOI 10.21037/jtd-20-1

PMID 32642098

发布时间 2022-08-17

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交